Researchers have uncovered a new way to attack lymphoma by targeting a non-catalytic region of a key regulatory enzyme, rather than its traditional active site. Researchers at VCU Massey Comprehensive ...

Citius Oncology announced a distribution agreement with Uniphar, a Dublin-based international healthcare services company, to provide access to denileukin diftitox (Lymphir) across Western and Eastern ...

A new study identifies an extreme but effective way that brain immune cells can prevent the parasite Toxoplasma gondii from spreading: they kill themselves to eliminate the dangerous microbes they ...

New research finds that sleep is essential for protecting brain mitochondria by transferring toxic metabolic waste from neurons to glial cells for disposal.

Extreme endurance running damages red blood cells in ways that may affect their ability to function properly, according to a ...

Innovations in imaging and genetic engineering are coming together to probe the biophysics of cytoplasm inside living animals.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

How does our DNA store the massive amount of information needed to build a human being? And what happens when it's stored incorrectly? Jesse Dixon, MD, Ph.D., has spent years studying the way this ...

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to treat blindness and the visually impaired.

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found.

Indian American researcher developing a novel type of living T cell-based therapy to tackle obesity-induced diabetes ...